0,747  0,005  Cognition disorders treatment
0,677  0,003  Antiemetic
0,674  0,010  Antipsychotic
0,670  0,010  Antiparkinsonian
0,639  0,014  Respiratory analeptic
0,623  0,002  Dopamine transporter inhibitor
0,618  0,003  5 Hydroxytryptamine uptake stimulant
0,612  0,004  5 Hydroxytryptamine uptake inhibitor
0,613  0,015  Antidepressant
0,605  0,007  Dependence treatment
0,605  0,014  5 Hydroxytryptamine release stimulant
0,594  0,018  Mood disorders treatment
0,565  0,018  Anxiolytic
0,554  0,017  Analeptic
0,541  0,005  Irritable Bowel syndrome treatment
0,535  0,004  Pneumotoxic
0,523  0,009  Psychostimulant
0,482  0,006  Antimigraine
0,482  0,009  Anesthetic general
0,485  0,021  Cardiovascular analeptic
0,508  0,047  Analgesic
0,482  0,022  NOS3 expression inhibitor
0,483  0,027  Ulceration
0,467  0,026  CTGF expression inhibitor
0,468  0,028  Spasmolytic
0,474  0,034  GABA C receptor rho-3 antagonist
0,489  0,064  Caspase 9 stimulant
0,426  0,004  Adrenaline uptake inhibitor
0,452  0,031  FMO1 substrate
0,474  0,054  TNF expression inhibitor
0,422  0,005  Antiparkinsonian, tremor relieving
0,416  0,011  Prostatic (benign) hyperplasia treatment
0,414  0,010  Prostate disorders treatment
0,408  0,004  Opioid kappa receptor antagonist
0,419  0,023  Cardiodepressant
0,411  0,015  FMO3 substrate
0,398  0,016  Abortion inducer
0,388  0,012  Antiacne
0,403  0,038  Nootropic
0,369  0,005  Opioid antagonist
0,367  0,007  5 Hydroxytryptamine 1E antagonist
0,380  0,021  Flavin-containing monooxygenase substrate
0,371  0,022  Sedative
0,362  0,014  Tyrosine 3 hydroxylase inhibitor
0,350  0,005  Sigma receptor antagonist
0,408  0,065  GST A substrate
0,347  0,014  Attention deficit/hyperactivity disorder treatment
0,345  0,014  Cholinergic
0,375  0,051  Aldehyde oxidase inhibitor
0,360  0,040  Sensitization
0,312  0,003  5 Hydroxytryptamine 3A agonist
0,312  0,004  Movement disorders treatment
0,309  0,005  Opioid mu receptor antagonist
0,332  0,028  Antiparkinsonian, rigidity relieving
0,313  0,013  Cholinergic antagonist
0,312  0,015  Alpha-N-acetylglucosaminidase inhibitor
0,308  0,013  Acetylcholine antagonist
0,307  0,013  Acetylcholine M1 receptor antagonist
0,323  0,035  Sigma receptor agonist
0,340  0,057  Calcium channel activator
0,286  0,005  Constipation treatment
0,286  0,009  Antismoking
0,319  0,044  Antineoplastic (liver cancer)
0,326  0,051  UGT2B4 substrate
0,278  0,004  Acetylcholine release stimulant
0,324  0,053  UGT1A9 substrate
0,284  0,013  Cocaine dependence treatment
0,276  0,007  Acetylcholine agonist
0,334  0,065  CYP2D6 substrate
0,312  0,046  Superoxide dismutase inhibitor
0,269  0,004  Acetylcholine muscarinic agonist
0,269  0,004  mTOR complex 1 inhibitor
0,297  0,035  Gastrin inhibitor
0,344  0,083  CYP2C9 substrate
0,304  0,045  GST M1-1 substrate
0,268  0,012  Acetylcholine muscarinic antagonist
0,263  0,008  Acetylcholine nicotinic antagonist
0,306  0,053  Radiosensitizer
0,344  0,094  Antipruritic, allergic
0,255  0,005  Opioid delta receptor antagonist
0,260  0,010  VEGF expression inhibitor
0,314  0,064  Interleukin 2 agonist
0,347  0,098  Antineoplastic (breast cancer)
0,273  0,025  Skeletal muscle relaxant
0,259  0,014  Antitussive
0,330  0,086  CYP3A4 substrate
0,280  0,036  Muscle relaxant
0,289  0,048  DNA synthesis inhibitor
0,265  0,026  Anesthetic
0,272  0,033  Antialcoholic
0,299  0,061  Antihypoxic
0,254  0,019  UGT2B9 substrate
0,288  0,054  Interleukin agonist
0,268  0,035  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,233  0,004  Acetylcholine M1 receptor agonist
0,232  0,004  Prokinetic
0,234  0,006  Antineoplastic alkaloid
0,288  0,062  Embryotoxic
0,336  0,110  Antibacterial
0,289  0,065  Teratogen
0,229  0,010  Antineoplastic, alkylator
0,221  0,003  Vesicle monoamine transporter inhibitor
0,247  0,029  Hair growth stimulant
0,279  0,066  DNA damaging
0,232  0,019  UGT2B10 substrate
0,246  0,038  Eye irritation, high
0,266  0,060  Potassium channel (Voltage-sensitive) blocker
0,293  0,088  Prostate cancer treatment
0,227  0,022  5 Hydroxytryptamine 2B antagonist
0,299  0,094  Transcription factor NF kappa B inhibitor
0,208  0,003  Narcotic antagonist
0,209  0,004  Peristaltic stimulant
0,271  0,069  Amyotrophic lateral sclerosis treatment
0,244  0,044  UGT2B7 substrate
0,223  0,025  Uterine stimulant
0,205  0,010  Creatine kinase inhibitor
0,239  0,044  UGT1A4 substrate
0,223  0,029  Toxic, respiratory center
0,200  0,006  Dopamine uptake inhibitor
0,283  0,093  AR expression inhibitor
0,270  0,081  Radioprotector
0,306  0,120  Histamine release inhibitor
0,196  0,009  Prolactin inhibitor
0,215  0,028  Anesthetic local
0,222  0,037  Antineoplastic (squamous cell carcinoma)
0,343  0,158  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,260  0,076  Antiprotozoal (Trypanosoma)
0,203  0,020  GABA C receptor agonist
0,237  0,058  RNA-directed DNA polymerase inhibitor
0,181  0,002  Antidote, organophosphates
0,181  0,008  Acetylcholine M2 receptor antagonist
0,173  0,004  Acetylcholine M5 receptor agonist
0,174  0,005  Nicotinic alpha4beta2 receptor antagonist
0,267  0,099  Caspase 3 stimulant
0,202  0,034  Phobic disorders treatment
0,201  0,033  5 Hydroxytryptamine antagonist
0,225  0,058  UGT1A1 substrate
0,201  0,034  Carcinogenic, group 1
0,176  0,010  Neuronal nicotinic receptor antagonist
0,204  0,038  Antidote
0,169  0,004  Nicotinic receptor alpha4 subunit antagonist
0,210  0,047  5 Hydroxytryptamine 3E antagonist
0,203  0,040  Acute respiratory distress syndrome (ARDS) treatment
0,173  0,010  Ca2+-transporting ATPase inhibitor
0,174  0,011  Acetylcholine nicotinic agonist
0,253  0,091  Antineoplastic (ovarian cancer)
0,200  0,038  Antirickettsial
0,197  0,036  Arachidonic acid antagonist
0,166  0,008  5 Hydroxytryptamine 3 antagonist
0,226  0,068  Antiviral (West Nile virus)
0,178  0,020  Pregnane X receptor agonist
0,200  0,043  Aldehyde oxidase substrate
0,167  0,011  GST T1-1 substrate
0,179  0,022  Bronchodilator
0,209  0,053  Antiviral (Hepatitis)
0,181  0,025  Hearing loss treatment
0,229  0,075  HERG channel blocker
0,175  0,022  Antiprotozoal (Babesia)
0,163  0,013  Analgesic, opioid
0,151  0,005  5 Hydroxytryptamine 3 agonist
0,156  0,012  Antidote, mercury
0,191  0,048  Antiviral (Hepatitis C)
0,146  0,007  Nicotinic receptor alpha7 subunit antagonist
0,160  0,021  Sphingomyelinase inhibitor
0,171  0,032  Cystathionine beta-synthase inhibitor
0,244  0,106  Hypoxia-inducible factor 1 alpha inhibitor
0,184  0,050  UGT2B15 substrate
0,164  0,032  Ferrochelatase inhibitor
0,190  0,058  Antimutagenic
0,138  0,007  5-Alpha-reductase inhibitor
0,221  0,092  Tumour necrosis factor alpha release inhibitor
0,297  0,168  5 Hydroxytryptamine release inhibitor
0,134  0,007  5 Hydroxytryptamine 3A antagonist
0,141  0,014  Antileprosy
0,217  0,091  Antineoplastic (cervical cancer)
0,155  0,030  Contraceptive female
0,132  0,009  Opioid agonist
0,126  0,005  Nicotinic alpha3beta2 receptor antagonist
0,212  0,091  Antihypotensive
0,191  0,070  P-glycoprotein inhibitor
0,150  0,029  UDP-glucose 4-epimerase inhibitor
0,154  0,034  GABA receptor agonist
0,236  0,116  CYP2D6 inhibitor
0,140  0,020  UGT2B11 substrate
0,127  0,008  Sleep apnea treatment
0,148  0,030  Antiviral (Influenza B)
0,169  0,052  GABA C receptor rho-2 antagonist
0,131  0,014  Acetylcholine M4 receptor antagonist
0,152  0,036  Gastritis treatment
0,139  0,023  Triose-phosphate isomerase inhibitor
0,135  0,019  5 Hydroxytryptamine 1F antagonist
0,140  0,024  Anabolic
0,125  0,009  Androgen agonist
0,119  0,005  Nicotinic receptor beta4 subunit antagonist
0,230  0,117  Insulysin inhibitor
0,138  0,026  Androgen antagonist
0,190  0,078  Antiviral (Ebola)
0,149  0,037  Excitatory amino acid transporter EAAC1 inhibitor
0,179  0,068  Succinate dehydrogenase inhibitor
0,166  0,055  Genotoxic
0,132  0,021  Tourette's syndrome treatment
0,117  0,008  Opioid kappa receptor agonist
0,128  0,018  Dopamine D1 antagonist
0,240  0,131  Antineoplastic (lung cancer)
0,264  0,155  Analgesic, non-opioid
0,147  0,039  Microtubule formation inhibitor
0,120  0,013  Alpha tubulin antagonist
0,173  0,066  ATPase inhibitor
0,115  0,008  Nicotinic receptor alpha3 subunit antagonist
0,115  0,008  Dopamine D5 antagonist
0,111  0,005  5-Alpha-reductase 2 inhibitor
0,111  0,005  Antihemophilic
0,150  0,045  Heat shock protein 70 antagonist
0,149  0,045  5 Hydroxytryptamine 2 antagonist
0,121  0,017  mTOR complex 2 inhibitor
0,132  0,029  Acetylcholine M3 receptor agonist
0,150  0,047  Alkylator
0,156  0,054  Adenylate cyclase stimulant
0,104  0,004  5-Alpha-reductase 1 inhibitor
0,113  0,015  Glycine receptor agonist
0,162  0,065  Acaricide
0,130  0,032  GABA C receptor rho-1 antagonist
0,170  0,073  Antipruritic
0,105  0,009  Cyclin-dependent kinase 6 inhibitor
0,156  0,059  SULT1A3 substrate
0,104  0,009  Glutamate (mGluR7) antagonist
0,214  0,119  CYP2C19 substrate
0,154  0,060  CNS active muscle relaxant
0,158  0,064  Antineoplastic (carcinoma)
0,125  0,032  Carcinogenic, group 2A
0,234  0,141  Vasodilator, peripheral
0,117  0,025  Bromodomain-containing protein 2 inhibitor
0,126  0,034  Mental retardation treatment
0,184  0,093  Neurotrophic factor enhancer
0,122  0,031  Antispirochetal
0,160  0,069  Diuretic
0,179  0,088  Non-steroidal antiinflammatory agent
0,178  0,088  Cytotoxic
0,178  0,088  CYP2B6 inhibitor
0,101  0,012  Antimycoplasmal
0,132  0,044  Antiviral (Poxvirus)
0,100  0,013  Nicotinic neuronal receptor agonist
0,190  0,103  UGT1A6 substrate
0,113  0,028  GABA A receptor agonist
0,156  0,071  Interferon gamma antagonist
0,227  0,142  Cholesterol antagonist
0,150  0,066  Cell wall synthesis inhibitor
0,124  0,040  Obsessive-compulsive disorder treatment
0,188  0,104  VCAM1 expression inhibitor
0,168  0,084  Antipruritic, non-allergic
0,128  0,045  GABA C receptor antagonist
0,135  0,051  Antiviral (Papilloma)
0,102  0,019  Narcolepsy treatment
0,111  0,029  Tocolytic
0,168  0,085  Diabetic retinopathy treatment
0,087  0,006  5 Hydroxytryptamine 3B antagonist
0,094  0,012  Nicotinic alpha7 receptor agonist
0,114  0,034  Dopamine antagonist
0,157  0,077  UGT1A3 substrate
0,206  0,127  Chemoprotective
0,109  0,031  Dyspepsia treatment
0,117  0,039  Electrolyte absorption antagonist
0,102  0,024  Polo-like kinase-2 inhibitor
0,125  0,048  NAT2 substrate
0,096  0,019  Alcohol oxidase inhibitor
0,093  0,018  Protein kinase C beta inhibitor
0,124  0,050  Mucolytic
0,221  0,147  CYP3A4 inhibitor
0,083  0,009  Anesthetic inhalation
0,098  0,024  CC chemokine 5 receptor agonist
0,093  0,020  MAP kinase kinase 7 inhibitor
0,089  0,017  Antiviral (Parainfluenza)
0,126  0,054  Alpha 2b adrenoreceptor antagonist
0,218  0,146  Antineoplastic (brain cancer)
0,083  0,012  5 Hydroxytryptamine 4 antagonist
0,104  0,033  Antibiotic
0,108  0,037  Polo-like kinase-1 inhibitor
0,198  0,127  Proliferative diseases treatment
0,110  0,040  Interleukin 12 antagonist
0,096  0,026  Premenstrual syndrome treatment
0,134  0,064  Antihelmintic (Trematoda)
0,080  0,011  Alpha-mannosidase inhibitor
0,090  0,021  Acetylcholine M3 receptor antagonist
0,121  0,053  Falcipain 3 inhibitor
0,087  0,020  Uterine relaxant
0,089  0,022  Argininosuccinate synthase inhibitor
0,094  0,028  Dopamine D4 antagonist
0,087  0,021  Acetylcholine M5 receptor antagonist
0,130  0,065  Carcinogenic, group 3
0,178  0,113  Cyclic AMP phosphodiesterase inhibitor
0,096  0,032  Glutamate decarboxylase inhibitor
0,072  0,008  Antihyperaldosteronism
0,116  0,052  Alpha 2c adrenoreceptor antagonist
0,167  0,102  I kappa B kinase epsilon inhibitor
0,067  0,004  Nicotinic alpha3beta4 receptor agonist
0,264  0,200  Apoptosis agonist
0,132  0,069  Antiprotozoal (Trichomonas)
0,087  0,025  Carbamoyl phosphate synthetase inhibitor
0,070  0,007  Acetylcholine M4 receptor agonist
0,096  0,034  Dopamine D2 antagonist
0,096  0,035  Na+ K+ transporting ATPase inhibitor
0,125  0,064  DNA repair enzyme inhibitor
0,076  0,017  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,121  0,062  Antifungal (Pneumocystis)
0,171  0,112  Histone acetyltransferase inhibitor
0,262  0,203  Alzheimer's disease treatment
0,101  0,043  NADH dehydrogenase inhibitor
0,085  0,027  Beta tubulin antagonist
0,112  0,055  DOPA decarboxylase inhibitor
0,109  0,052  Antihypermotility
0,155  0,098  DNA methyltransferase I inhibitor
0,220  0,164  Vasodilator, coronary
0,181  0,125  Nitric-oxide synthase stimulant
0,121  0,067  Adenylate cyclase inhibitor
0,073  0,019  Prolactin release inhibitor
0,208  0,154  Immunomodulator
0,079  0,026  SULT2A1 substrate
0,115  0,061  SULT1A1 substrate
0,145  0,092  Antihelmintic (Nematodes)
0,108  0,055  Adenylate kinase inhibitor
0,073  0,021  Phosphodiesterase 1A inhibitor
0,085  0,033  Vanilloid 4 agonist
0,150  0,099  Carcinogenic
0,055  0,004  Nicotinic alpha4beta2 receptor agonist
0,066  0,015  Phosphodiesterase 7A inhibitor
0,106  0,056  Chronic obstructive bronchitis treatment
0,109  0,059  Expectorant
0,110  0,062  Protein kinase C gamma inhibitor
0,119  0,070  Antiprotozoal (Amoeba)
0,129  0,081  Neurotrophic factor
0,086  0,038  Phosphofructokinase-1 inhibitor
0,089  0,042  Estrogen-related receptor beta agonist
0,063  0,015  Mannosidase inhibitor
0,052  0,005  Nociceptin (N/OFQ) receptor agonist
0,095  0,050  Histamine N-methyltransferase inhibitor
0,111  0,066  Nav1.5 sodium channel blocker
0,078  0,033  Female sexual dysfunction treatment
0,095  0,051  Glutamate release inhibitor
0,061  0,017  Adenylate cyclase 1 inhibitor
0,086  0,043  Porphobilinogen synthase inhibitor
0,071  0,027  Cyclin D1 inhibitor
0,073  0,030  MDM2 inhibitor
0,134  0,091  Sphingosine 1-phosphate receptor 5 antagonist
0,046  0,004  Antibiotic Quinolone-like
0,084  0,042  Viral attachment inhibitor
0,113  0,072  Interleukin 8 antagonist
0,073  0,032  Phosphodiesterase VII inhibitor
0,048  0,007  Vanilloid 4 antagonist
0,069  0,029  Corticotropin releasing factor 2 receptor antagonist
0,094  0,054  Restless leg syndrome treatment
0,133  0,094  Neuropeptide Y1 antagonist
0,093  0,054  Phosphodiesterase I inhibitor
0,055  0,016  Guanylate cyclase inhibitor
0,101  0,062  Sulfotransferase substrate
0,081  0,044  Glutamate dehydrogenase inhibitor
0,061  0,024  Glycine transporter inhibitor
0,196  0,160  CYP1A2 substrate
0,262  0,225  Antineoplastic (solid tumors)
0,086  0,049  Caspase 7 inhibitor
0,044  0,007  Adenosine uptake inhibitor
0,062  0,026  Pregnane X receptor antagonist
0,052  0,016  Dopamine D5 agonist
0,089  0,053  Sodium/hydrogen exchanger 5 inhibitor
0,085  0,049  Glycine receptor antagonist
0,046  0,011  Sigma 2 receptor antagonist
0,049  0,014  RNA-directed RNA polymerase stimulant
0,135  0,100  Neuropathy treatment
0,103  0,069  Choleretic
0,044  0,010  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,071  0,037  Dopamine D3 antagonist
0,038  0,005  Vesicular acetylcholine transporter inhibitor
0,084  0,052  T cell inhibitor
0,075  0,043  CXC chemokine receptor antagonist
0,180  0,149  Antineoplastic (colorectal cancer)
0,060  0,029  Acetylcholine M2 receptor agonist
0,055  0,024  Histamine H4 receptor antagonist
0,050  0,019  Nerve growth factor antagonist
0,046  0,015  Opioid delta receptor agonist
0,056  0,026  Topoisomerase II beta inhibitor
0,123  0,092  Nav1.6 sodium channel blocker
0,094  0,064  Phosphodiesterase 7B inhibitor
0,055  0,026  Opioid mu receptor agonist
0,178  0,149  Huntington's disease treatment
0,061  0,032  Bromodomain-containing protein 4 inhibitor
0,054  0,025  Glucose-6-phosphate isomerase inhibitor
0,058  0,029  Histamine agonist
0,042  0,013  Tubulin agonist
0,068  0,040  5 Hydroxytryptamine 1D antagonist
0,062  0,035  5 Hydroxytryptamine 6 antagonist
0,107  0,080  Menstruation disorders treatment
0,073  0,046  Orexin receptor 1 antagonist
0,091  0,064  Protein kinase C zeta inhibitor
0,142  0,117  Lipocortins synthesis antagonist
0,082  0,056  Antineoplastic antibiotic
0,112  0,087  Cathepsin H inhibitor
0,083  0,058  Histamine H2 receptor antagonist
0,119  0,094  Protein kinase stimulant
0,170  0,145  Antineoplastic (colon cancer)
0,038  0,013  Sigma 1 receptor antagonist
0,037  0,013  Protein kinase C beta I inhibitor
0,089  0,065  Antihistaminic
0,051  0,027  Cytokine production stimulant
0,092  0,069  Phosphodiesterase 6D inhibitor
0,074  0,051  Potassium channel (Tandem pore domain) blocker
0,030  0,007  5 Hydroxytryptamine 4 agonist
0,165  0,143  Immunostimulant
0,086  0,064  Gastroesophageal reflux disease treatment
0,042  0,021  Arginase inhibitor
0,064  0,043  Calcium channel P-type blocker
0,144  0,123  DNA methylase inhibitor
0,053  0,032  Prolyl endopeptidase inhibitor
0,032  0,011  Antibiotic Naphthyridine-like
0,143  0,122  LDLR expression enhancer
0,054  0,034  mTOR inhibitor
0,070  0,050  Histidine decarboxylase inhibitor
0,049  0,030  Aldosterone antagonist
0,038  0,019  Ceramide glucosyltransferase inhibitor
0,114  0,097  Antifungal enhancer
0,023  0,005  Nicotinic alpha4 receptor agonist
0,030  0,015  HCV NS5A inhibitor
0,042  0,026  Kainate receptor agonist
0,038  0,022  Nociceptin (N/OFQ) receptor antagonist
0,086  0,071  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,118  0,102  Sphingosine 1-phosphate receptor 2 antagonist
0,030  0,015  LFA antagonist
0,049  0,034  HCV NS3/NS4A protease inhibitor
0,065  0,050  Glutamate (mGluR6) antagonist
0,160  0,145  Cytostatic
0,033  0,018  Dipeptidyl peptidase I inhibitor
0,030  0,016  Estrogen-related receptor gamma antagonist
0,109  0,094  Contraceptive
0,044  0,030  Glutamate (mGluR group III) antagonist
0,052  0,038  Protein 50S ribosomal subunit inhibitor
0,053  0,039  Acyl-CoA dehydrogenase inhibitor
0,038  0,025  Delayed rectifier potassium channel blocker
0,110  0,097  Toll-Like receptor 9 antagonist
0,116  0,104  Peroxidase inhibitor
0,146  0,134  Anticonvulsant
0,045  0,033  Glutamate (mGluR5) agonist
0,048  0,036  CC chemokine receptor 2B antagonist
0,016  0,005  Cyclin D2 inhibitor
0,050  0,039  Aconitate hydratase inhibitor
0,081  0,070  GST P1-1 substrate
0,060  0,051  5 Hydroxytryptamine 1B antagonist
0,140  0,130  Neurotensin receptor agonist
0,018  0,009  NMDA receptor phencyclidine site antagonist
0,067  0,058  Aminopeptidase I inhibitor
0,076  0,068  Histamine antagonist
0,068  0,059  Phospholipase D inhibitor
0,115  0,106  Cytidine deaminase inhibitor
0,059  0,051  Phosphodiesterase 1C inhibitor
0,027  0,020  Hedgehog signaling activator
0,022  0,015  Glutamate (mGluR1a) agonist
0,046  0,039  Dopamine beta hydroxylase inhibitor
0,061  0,054  5 Hydroxytryptamine agonist
0,091  0,085  UGT2B1 substrate
0,056  0,050  Ryanodine receptor antagonist
0,042  0,036  Potassium channel small-conductance Ca-activated blocker
0,026  0,020  Histamine H3 receptor agonist
0,036  0,031  Glutamate (mGluR8) agonist
0,073  0,068  5 Hydroxytryptamine 2C antagonist
0,048  0,043  Melanin-concentrating hormone receptor 1 antagonist
0,055  0,050  Lipocortins synthesis agonist
0,072  0,067  Histamine H1 receptor antagonist
0,043  0,039  Glutamate (mGluR group I) agonist
0,061  0,056  Orexin receptor antagonist
0,080  0,076  Granulocyte macrophage colony stimulating factor agonist
0,029  0,025  HCV NS5B polymerase inhibitor
0,075  0,072  Antiprotozoal activity enhancer
0,080  0,077  HIV-1 integrase (Overall Integration) inhibitor
0,027  0,024  5 Hydroxytryptamine 6 agonist
0,137  0,135  Phospholipase C inhibitor
0,027  0,025  Peptide deformylase inhibitor
0,063  0,061  Anticholelithogenic
0,023  0,021  5 Hydroxytryptamine 1F agonist
0,091  0,089  Antihelmintic (Fasciola)
0,045  0,044  CC chemokine 5 receptor antagonist
0,083  0,081  Anticataract
0,085  0,083  Glutathione S-transferase substrate
0,037  0,036  Oxytocin agonist
0,087  0,086  Monophenol monooxygenase inhibitor
0,035  0,035  Membrane dipeptidase inhibitor
0,048  0,047  Dipeptidyl peptidase inhibitor
0,148  0,147  NOS2 expression inhibitor

